Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Molecular Therapy. Nucleic Acids|April 8, 2015
Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In VivoAlex Mas Monteys, Matthew J Wilson, Ryan L Boudreau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2014
Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7Pavitra S Ramachandran, Ryan L Boudreau, Kellie A Schaefer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 26, 2009
Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease miceRyan L Boudreau, Jodi L McBride, Inês Martins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2011
Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's diseaseJodi L McBride, Mark R Pitzer, Ryan L Boudreau, et al.
Journal of Huntington'S Disease|July 27, 2014
Rhes suppression enhances disease phenotypes in Huntington's disease miceJohn H Lee, Matthew J Sowada, Ryan L Boudreau, et al.
Nucleic Acids Research|September 4, 2012
siSPOTR: a tool for designing highly specific and potent siRNAs for human and mouseRyan L Boudreau, Ryan M Spengler, Ray H Hylock, et al.
Plos One|April 25, 2014
RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degenerationPavitra S Ramachandran, Sajag Bhattarai, Pratibha Singh, et al.
Nucleic Acids Research|July 16, 2016
Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIPRyan M Spengler, Xiaoming Zhang, Congsheng Cheng, et al.
Neuron|January 7, 2014
Transcriptome-wide discovery of microRNA binding sites in human brainRyan L Boudreau, Peng Jiang, Brian L Gilmore, et al.
Pageof 23